Xilio Therapeutics, Inc. (XLO) Operating margin 2024–2025
Xilio Therapeutics, Inc. (XLO) operating margin by fiscal year — reported operating income divided by reported revenue.
-95.9%FY2025 · since FY2024: -954.9% → -95.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -95.9% | +859.0 pp |
| FY2024 | -954.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice